Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries.

Valovirta E, Scadding G.

Curr Med Res Opin. 2009 Aug;25(8):2061-7. doi: 10.1185/03007990903116834.

PMID:
19580372
3.

Pediatric allergy medications: review of currently available formulations.

Scadding G.

Curr Med Res Opin. 2009 Aug;25(8):2069-79. doi: 10.1185/03007990903116875. Review.

PMID:
19580371
4.

Safety of desloratadine syrup in children.

Bloom M, Staudinger H, Herron J.

Curr Med Res Opin. 2004 Dec;20(12):1959-65.

PMID:
15701213
5.

Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.

Torkildsen GL, Gomes P, Welch D, Gopalan G, Srinivasan S.

Clin Exp Allergy. 2009 Jul;39(7):1052-9. doi: 10.1111/j.1365-2222.2009.03224.x. Epub 2009 Mar 10.

PMID:
19302250
6.
7.

Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.

Bachert C, Maurer M.

Clin Drug Investig. 2010;30(2):109-22. doi: 10.2165/11530930-000000000-00000. Review.

PMID:
20067329
8.

Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.

Demoly P, Dreyfus I, Dhivert-Donnadieu H, Mesbah K.

Ann Allergy Asthma Immunol. 2009 Sep;103(3):260-6. doi: 10.1016/S1081-1206(10)60191-3.

PMID:
19788025
10.

The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.

Sullivan PW, Navaratnam P, Lorber R, Shekar T.

Curr Med Res Opin. 2010 Jun;26(6):1389-97. doi: 10.1185/03007991003750381.

PMID:
20384438
11.
12.

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK.

J Allergy Clin Immunol. 2010 Mar;125(3):676-82. doi: 10.1016/j.jaci.2009.11.047.

PMID:
20226302
13.

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.

Noehr-Jensen L, Damkier P, Bidstrup TB, Pedersen RS, Nielsen F, Brosen K.

Eur J Clin Pharmacol. 2006 Jun;62(6):437-45. Epub 2006 Apr 28.

PMID:
16770647
14.

A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.

Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH.

Ann Allergy Asthma Immunol. 2003 Oct;91(4):375-85.

PMID:
14582817
16.

The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.

Dizdar EA, Sekerel BE, Keskin O, Kalayci O, Adalioglu G, Dogan C, Tuncer A.

Int J Pediatr Otorhinolaryngol. 2007 Jun;71(6):843-9. Epub 2007 Mar 7.

PMID:
17346807
17.

Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.

DuBuske L.

Am J Clin Dermatol. 2007;8(5):271-83. Review.

PMID:
17902729
18.

Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.

Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P.

Am J Rhinol Allergy. 2011 Jan-Feb;25(1):e1-6. doi: 10.2500/ajra.2011.25.3540.

PMID:
21711959
19.

Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study.

Ferrer M, Morais-Almeida M, Guizova M, Khanferyan R.

Clin Drug Investig. 2010;30(1):15-34. doi: 10.2165/11530910-000000000-00000.

PMID:
19995095
20.

Pharmacokinetics of desloratadine in children between 2 and 11 years of age.

Gupta S, Khalilieh S, Kantesaria B, Banfield C.

Br J Clin Pharmacol. 2007 May;63(5):534-40.

Supplemental Content

Support Center